HAL (France)open access
Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics
AZD9977, Non-steroidal mineralocorticoid receptor antagonists, Finerenone, 2, Hypertension, 0, Chronic kidney disease, Heart failure
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 677152
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.